CYTK Q2 2019 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+14.8% YoY

Gross Profit

-$17M-236.5% margin

Operating Income

-$27M-374.3% margin

Net Income

-$32M-450.0% margin

EPS (Diluted)

$-0.56

QoQ Revenue Growth

-15.7%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$198M

Total Liabilities

$203M

Stockholders' Equity

-$5M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+14.8%
Gross Profit	-$17M	-$15M	-9.8%
Operating Income	-$27M	-$23M	-14.1%
Net Income	-$32M	-$28M	-16.7%

Revenue Segments

Research And Development

$7M100%